These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 17970532

  • 1. [Remission with long-lasting antipsychotic agent].
    Radics J.
    Neuropsychopharmacol Hung; 2007 Jun; 9(2):91-2. PubMed ID: 17970532
    [Abstract] [Full Text] [Related]

  • 2. Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.
    Batalla A, Vera M, Torra M, Parellada E.
    J Clin Psychopharmacol; 2010 Feb; 30(1):92-4. PubMed ID: 20075665
    [No Abstract] [Full Text] [Related]

  • 3. Follow-up of a pregnancy with risperidone microspheres.
    Dabbert D, Heinze M.
    Pharmacopsychiatry; 2006 Nov; 39(6):235. PubMed ID: 17124649
    [Abstract] [Full Text] [Related]

  • 4. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
    Portier A, Sarfati Y.
    Encephale; 2000 Nov; 26(4):75-7. PubMed ID: 11064844
    [Abstract] [Full Text] [Related]

  • 5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 6. Risperidone-induced anxiety might also develop 'awakening' phenomenon.
    Hori M, Shiraishi H.
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):682. PubMed ID: 10687752
    [No Abstract] [Full Text] [Related]

  • 7. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD, Hake L, Benjamin AB, Adityanjee A.
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract] [Full Text] [Related]

  • 8. Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic feature.
    Katagai H, Yasui-Furukori N, Kikuchi A, Kaneko S.
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):568-70. PubMed ID: 17875038
    [Abstract] [Full Text] [Related]

  • 9. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
    Marinis TD, Saleem PT, Glue P, Arnoldussen WJ, Teijeiro R, Lex A, Latif MA, Medori R.
    Pharmacopsychiatry; 2007 Nov; 40(6):257-63. PubMed ID: 18030649
    [Abstract] [Full Text] [Related]

  • 10. Use of long-acting risperidone in the treatment of bipolar patients.
    Savas HA, Yumru M, Ozen ME.
    J Clin Psychopharmacol; 2006 Oct; 26(5):530-1. PubMed ID: 16974200
    [No Abstract] [Full Text] [Related]

  • 11. Risperidone-induced hepatotoxicity.
    Benazzi F.
    Pharmacopsychiatry; 1998 Nov; 31(6):241. PubMed ID: 9930641
    [No Abstract] [Full Text] [Related]

  • 12. [About the curability of schizophrenia].
    Gaszner P.
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):39-42. PubMed ID: 16167467
    [Abstract] [Full Text] [Related]

  • 13. Long-acting risperidone improves negative symptoms in stable psychotic patients.
    Curtis VA, Katsafouros K, Möller HJ, Medori R, Sacchetti E.
    J Psychopharmacol; 2008 May; 22(3):254-61. PubMed ID: 18308804
    [Abstract] [Full Text] [Related]

  • 14. Remission in schizophrenia: analysis in a naturalistic setting.
    Eberhard J, Levander S, Lindström E.
    Compr Psychiatry; 2009 May; 50(3):200-8. PubMed ID: 19374962
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic incidence of attempted suicide in paranoid schizophrenia. A case report].
    Boudehri R, Fethi H, Salem M, Brour S.
    Tunis Med; 1991 Dec; 69(12):737-41. PubMed ID: 1808790
    [No Abstract] [Full Text] [Related]

  • 16. Risperidone in the treatment of psychotic depression.
    Miodownik C, Lerner V.
    Clin Neuropharmacol; 2000 Dec; 23(6):335-7. PubMed ID: 11575868
    [Abstract] [Full Text] [Related]

  • 17. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):726-32. PubMed ID: 18096287
    [Abstract] [Full Text] [Related]

  • 18. Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone.
    Hergüner S, Bilge I, Yavuz Yilmaz A, Tüzün DU.
    Turk J Pediatr; 2006 Apr 01; 48(3):244-7. PubMed ID: 17172069
    [Abstract] [Full Text] [Related]

  • 19. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG, Risperidone Long-Acting Trial Investigators (R-LAI).
    Hum Psychopharmacol; 2009 Oct 01; 24(7):574-83. PubMed ID: 19790173
    [Abstract] [Full Text] [Related]

  • 20. Hashimoto encephalopathy responding to risperidone.
    Bismilla Z, Sell E, Donner E.
    J Child Neurol; 2007 Jul 01; 22(7):855-7. PubMed ID: 17715278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.